News

Gladstone in the News June 27, 2024

Gladstone Institutes Launches $350 Million Campaign to Hire Hundreds of Scientists

San Francisco Business Times—Gladstone President Deepak Srivastava explains how the fundraising campaign will help Gladstone seize the opportunity to understand disease at an unprecedented level, in part by advancing work in artificial intelligence in health care and medicine and by taking basic discoveries from the lab bench to patients' bedsides. (Subscription Required.)

Institutional News

Gladstone in the News June 19, 2024

Rare Gene Mutation Helps People Resist Alzheimer’s Disease

Washington Post—Gladstone Senior Investigator Yadong Huang offers commentary on a new study examining the protective power of the rare “Christchurch” gene variant against Alzheimer’s. (Subscription required)

Alzheimer’s Disease Huang Lab

Article June 18, 2024

Justin Eyquem Named a 2024 Pew-Stewart Scholar for Cancer Research

Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells.

Awards News Release Cancer Eyquem Lab

Video June 18, 2024

Out in Science: Creating Spaces for Success

Watch a recording from the 2024 Out in Science event, featuring Carolyn Bertozzi, Chanda Prescod-Weinstein, and Joanne Engel

LGBTQ Diversity

Gladstone in the News June 12, 2024

Podcast: ’The Voice Weekly’ Featuring Deepak Srivastava

The Voice of San Francisco—Gladstone President Deepak Srivastava, MD, talks about technologies driving the next wave of medicine, the importance of philanthropy dollars in fueling scientific breakthroughs, and how biotech is still breathing life into San Francisco's Mission Bay neighborhood.

Philanthropy Srivastava Lab Aging AI CRISPR/Gene Editing Stem Cells/iPSCs

Article June 4, 2024

Scientists Push Single-Molecule DNA Sequencing to the Next Level

Two new tools created at Gladstone Institutes allow scientists to study DNA at single-molecule resolution using fewer cells than previously required, with clear applications for cancer and many other diseases.

News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Genomics Human Genetics

Article May 29, 2024

CRISPR-Based Mapping Uncovers ‘Switches’ for Immune Genes Central to Health

A new study in Nature Genetics expands our understanding of immune regulation and autoimmunity—with findings that could also be used in the development of cancer immunotherapies.

News Release Autoimmune Diseases Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Marson Lab Pollard Lab Ye Lab AI CRISPR/Gene Editing

Article May 24, 2024

Scientists Leverage Machine Learning to Decode Gene Regulation in the Developing Human Brain

A team of researchers from Gladstone Institutes and UC San Francisco combined high-throughput experiments and machine learning to analyze more than 100,000 sequences in human brain cells.

News Release Research (Publication) Data Science and Biotechnology Pollard Lab AI Big Data Developmental Biology Disease Models Genomics Human Genetics

Article May 24, 2024

Visionary Philanthropists Establish Center to Harness Computational Biology for Cancer Research

A search for the brightest minds in cancer and AI led Hope and Sanjit Biswas to give in their own backyard.

Philanthropy Donor Stories Cancer Biswas Center for Transformative Computational Cancer Biology Data Science and Biotechnology Pollard Lab AI Big Data

Article May 10, 2024

Gladstone’s Deepak Srivastava Honored as Most Admired CEO by San Francisco Business Times

The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.

Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava Lab

Article April 19, 2024

A New Therapeutic Target for Traumatic Brain Injury

Research from Gladstone Institutes reveals that a blood coagulation protein is responsible for initiating toxic inflammation and neuron loss after a major head injury. The findings can inform new treatment strategies for a condition that often presents long-term health challenges.

News Release Dementia Traumatic Brain Injury Neurological Disease Akassoglou Lab

Article April 18, 2024

Computational Biology Pioneer Katie Pollard Elected as AAAS Fellow

The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new class of AAAS Fellows, a lifetime honor within the scientific community.

Awards News Release Data Science and Biotechnology Pollard Lab AI Big Data Genomics Human Genetics Microbiome

Video April 12, 2024

Developing the UC San Francisco Gender Affirming Health Program: from DIY to the Big Leagues

In this video recording from the 2024 Transgender Day of Visibility seminar, learn more about the development, launch, and growth of the UCSF Gender Affirming Health Program

LGBTQ Diversity

Article April 2, 2024

Gladstone Grad Student Shines on International Neuroscience Stage

In early 2024, Deanna Necula co-chaired a prestigious Gordon Research Seminar in Ventura, California

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Neurological Disease Paz Lab

Video March 22, 2024

LinkedIn for Job Searching

In this webinar, a former LinkedIn staffer shares behind-the-scenes insights to help you optimize the rate of return on the jobs you apply for.

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs